Keywords: گردش DNA تومور; Biomarkers; Circulating tumor DNA; Clinical trials; Clinical trial design; Total metabolic tumor volume;
مقالات ISI گردش DNA تومور (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: گردش DNA تومور; MM; Multiple Myeloma; ISS; Internationla Staging System; R-ISS; Revised International Staging System; CTCs; Circulating tumor cells; ctDNA; Circulating tumor DNA;
Keywords: گردش DNA تومور; Circulating tumor cells; Liquid biopsy; Prognostic biomarker; Predictive biomarker; Circulating tumor DNA; Clinical utility; Clinical application;
Keywords: گردش DNA تومور; AUC; area under the curve; CA19-9; carbohydrate antigen 19-9; CAF; cancer associated fibroblast; CD; cluster of differentiation; CEA; carcinoembryonic antigen; CEP8; chromosome enumeration probe 8; cfDNA; cell free DNA; cfNA; cell-free nucleic acid; CK; c
Keywords: گردش DNA تومور; uPA; urokinase plasminogen activator; PAI-1; plasminogen activator inhibitor 1; ctDNA; circulating tumor DNA; CTC; circulating tumor cells; PFS; progression-free survival; pCR; pathological complete response; SNVs; single nucleotide variants; CNVs; copy n
Keywords: گردش DNA تومور; CDXs; CTC-derived explants; CNV; copy number variation; CTCs; circulating tumor cells; CSCs; cancer stem cells; CtDNA; circulating tumor DNA; DCIS; ductal carcinoma in situ; ITH; intratumor heterogeneity; LCM; laser capture micro-dissection; NCCR; Nationa
Keywords: گردش DNA تومور; BRCA2; Circulating tumor DNA; Cell-free DNA; Liquid biopsy; Enzalutamide; Abiraterone; Castration-resistant prostate cancer; DNA repair;
Keywords: گردش DNA تومور; AI; aromatase inhibitor; AR; androgen receptor; CAF; cancer-associated fibroblast; CBR; clinical benefit rate; CDK; cyclin-dependent kinase; ctDNA; circulating tumor DNA; DNMT3B; DNA methyltransferase 3B; ER; estrogen receptor; ESR1; ER gene; HDAC1; histo
Keywords: گردش DNA تومور; ct-DNA; circulating tumor DNA; MSI; microsatellite instability; NCI; National Cancer Institute; NGP; next-generation panel; NGS; next-generation sequencing; WES; whole exome sequencing; WGS; whole genome sequencing;
Metal complexes of tridentate tripod ligands in medical imaging and therapy
Keywords: گردش DNA تومور; 2-TicNMe; tris(N-methylimidazol-2-yl)carbonil; 2-TipiPr2; tris(1,4-diisopropylimidazol-2-yl)phosphane; 4-TipH; tris(imidazole-4-yl)phosphane; AO; acridine orange; BBB; blood brain barrier; BBN; bombesin; bdmpza; 3,3-bis(3,5-dimethylpyrazol-1-yl)acetate; b
Keywords: گردش DNA تومور; Bladder cancer; Circulating tumor cells; Cell-free DNA; Circulating tumor DNA;
Keywords: گردش DNA تومور; Metastatic renal cell carcinoma; Circulating biomarkers; Circulating tumor cells; Circulating tumor DNA; VEGF therapies; Immunotherapy;
Keywords: گردش DNA تومور; CTC; circulating tumor cell; ctDNA; circulating tumor DNA; EM; electromagnetic; FDA; Food and Drug Administration; FDG; [18F]fluorodeoxyglucose; FFPE; formalin-fixed, paraffin-embedded; FNA; fine needle aspiration; NGS; next-generation sequencing; PET; po
Keywords: گردش DNA تومور; cell-free DNA; cell-free RNA; cell-free microRNA; cell-free circulating nucleic acids; circulating tumor DNA; circulating mutant DNA
Keywords: گردش DNA تومور; Circulating tumor cells; Circulating tumor DNA; Liquid biopsy; Pancreatic cancer;
Keywords: گردش DNA تومور; Predictive Markers; Prognostic Markers; Colorectal Cancer; Molecular Subtypes; RAS; BRAF; MSI; DNA Mismatch Repair; Immunotherapy; Targeted Therapy; Biologics; Anti-EGFR; Anti-VEGF; CCS; colon cancer subtypes; CIMP; CpG island methylator phenotype; CIN; c
Keywords: گردش DNA تومور; BBB; blood-brain barrier; BRCA; breast cancer associated; ER; estrogen receptor; CTC; circulating tumor cell; ctDNA; circulating tumor DNA; DRFI; distant recurrence-free interval; DTC; disseminated tumor cell; EMT; epithelial-to-mesenchymal transition;
Keywords: گردش DNA تومور; Chemotherapy; Imaging; Pancreatic cancer; Pathology; Radiotherapy; Targeted therapy; 18FDG-PET; 18F-fluorodeoxyglucose-positron emission tomography; 5FU; 5-fluorouracil; α-SMA; α-smooth muscular actin; AA; amino acid; APA; adapted physical activity; ATP
Keywords: گردش DNA تومور; Non-small-cell lung cancer; KRAS mutation; Circulating tumor cells; Circulating tumor DNA;
Keywords: گردش DNA تومور; Circulating tumor DNA; Liquid biopsy; Intra-tumor heterogeneity; Disease monitoring; Molecular resistance; Early detectionctDNA, circulating tumor DNA; MPS, massive parallel sequencing; MRD, minimal residual disease; NGS, Next Generation Sequencing; PCR,
Keywords: گردش DNA تومور; Trophoblastic tumor; Hydatidiform mole; Cell free DNA; Circulating tumor DNA; Molecular genotyping; Liquid biopsy
High-performance electrochemical sensing of circulating tumor DNA in peripheral blood based on poly-xanthurenic acid functionalized MoS2 nanosheets
Keywords: گردش DNA تومور; Poly-xanthurenic acid; MoS2 nanosheets; Electrochemical sensing; Circulating tumor DNA; Peripheral blood;
Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types
Keywords: گردش DNA تومور; PD-L1; Circulating tumor DNA; Liquid biopsy; Cancer;
ESR1 methylation in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancer
Keywords: گردش DNA تومور; Estrogen receptor; ESR1; Liquid biopsy; High-grade serous ovarian cancer; Circulating tumor DNA; Methylation specific PCR;
ctDNA and CTCs in Liquid Biopsy - Current Status and Where We Need to Progress
Keywords: گردش DNA تومور; Liquid biopsy; Circulating tumor DNA; Circulating tumor cells; Pre-analytical handling; Technology overview;
Circulating tumor DNA testing in advanced non-small cell lung cancer
Keywords: گردش DNA تومور; Circulating tumor DNA; Liquid biopsy; Biomarker; Non-small cell lung cancer; Epidermal growth factor receptor; Drug resistance;
Prognostic value of circulating cell-free DNA in patients with pancreatic cancer: A systemic review and meta-analysis
Keywords: گردش DNA تومور; CfDNA; circulating cell-free DNA; CA19-9; carbohydrate antigen 19-9; CA242; carbohydrate antigen 242; ctDNA; circulating tumor DNA; ddPCR; droplet digital polymerase chain reaction; BEAMing; beads, emulsions, amplification, and magnetics; OS; overall
Comparison of genetic profiles among primary lung tumor, metastatic lymph nodes and circulating tumor DNA in treatment-naïve advanced non-squamous non-small cell lung cancer patients
Keywords: گردش DNA تومور; AF; allelic fractions; ctDNA; circulating tumor DNA; cfDNA; circulating cell-free DNA; CNV; copy number variation; LOF; loss of function; maxAF; maximal AF; NGS; next-generation sequencing; NSCLC; non-small cell lung cancer; PFS; progression-free survival
A randomized phase II trial of trastuzumab plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with trastuzumab and taxanes: WJOG6110B/ELTOP
Keywords: گردش DNA تومور; Lapatinib; Trastuzumab; Beyond progression; PIK3CA; Brain metastasis; Circulating tumor DNA;
Exosomes as a liquid biopsy for lung cancer
Keywords: گردش DNA تومور; Alix; ALG 2 interacting protein X; ALK; anaplastic lymphoma kinase; AREG; Amphiregulin; Atg2; autophagy related protein 2; AUC; area under the curve; BAL; bronchoalveolar lavage; circRNA; circular RNA; CSE; cigarette smoke extract; CTC; circulating tumor
BRCA2 Reversion Mutation Associated With Acquired Resistance to Olaparib in Estrogen Receptor-positive Breast Cancer Detected by Genomic Profiling of Tissue and Liquid Biopsy
Keywords: گردش DNA تومور; BRCA reversion; Circulating tumor DNA; ctDNA; Metastatic breast cancer; PARP inhibitor;
Electrochemically mediated in situ growth of electroactive polymers for highly sensitive detection of double-stranded DNA without sequence-preference
Keywords: گردش DNA تومور; Electrochemical DNA biosensor; Peptide nucleic acid; Atom transfer radical polymerization; Double-stranded DNA; Circulating tumor DNA; Liquid biopsy;
Evaluation of commercial kits for purification of circulating free DNA
Keywords: گردش DNA تومور; Circulating free DNA; Circulating tumor DNA; Liquid biopsy; Biomarker;
Non-invasive detection of actionable mutations in advanced non-small-cell lung cancer using targeted sequencing of circulating tumor DNA
Keywords: گردش DNA تومور; Non-small-cell lung cancer; Non-invasive; Circulating tumor DNA; Actionable mutations; Targeted sequencing; Molecular barcode;
A versatile label-free electrochemical biosensor for circulating tumor DNA based on dual enzyme assisted multiple amplification strategy
Keywords: گردش DNA تومور; Electrochemical biosensor; Circulating tumor DNA; Dual enzyme assisted multiple amplification;
Analysis of Cell-Free DNA to Assess Risk of Tumoremia Following Endoscopic Ultrasound Fine-Needle Aspiration of Pancreatic Adenocarcinomas
Keywords: گردش DNA تومور; Cancer Detection; Molecular Cytogenetic Biomarker; Diagnostic; Pathology; cfDNA; cell-free DNA; CTC; circulating tumor cell; ctDNA; circulating tumor DNA; ECM; epithelial cellular material; EUS; endoscopic ultrasound; FNA; fine needle aspiration; HV; hepa
Dynamics of EGFR Mutation Load in Plasma for Prediction of Treatment Response and Disease Progression in Patients With EGFR-Mutant Lung Adenocarcinoma
Keywords: گردش DNA تومور; Circulating tumor DNA; Clonal dynamics; EGFR; Liquid biopsy; Targeted therapy;
Circulating tumor DNA - Current state of play and future perspectives
Keywords: گردش DNA تومور; BEAMing; beads, emultion, amplification, magnetics; bp; base pairs; cfDNA; circulating cell-free DNA; CNS; central nervous system; CRC; colorectal cancer; CSF; cerebrospinal fluid; CTC; circulating tumor Cell; ctDNA; circulating tumor DNA; ddPCR; droplet
Nanoplasmonic sensors for detecting circulating cancer biomarkers
Keywords: گردش DNA تومور; Circulating tumor cells; microRNA; Circulating tumor DNA; Exosomes; Nanoplasmonics; SERS; LSPR;
Dual occurrence of ALK G1202R solvent front mutation and small cell lung cancer transformation as resistance mechanisms to second generation ALK inhibitors without prior exposure to crizotinib. Pitfall of solely relying on liquid re-biopsy?
Keywords: گردش DNA تومور; Small cell lung cancer transformation; Lorlatinib; ALK G1202R solvent front mutation; Circulating tumor DNA; Rb1 C706Y; ALK+ NSCLC;
Capturing tumor heterogeneity and clonal evolution in solid cancers using circulating tumor DNA analysis
Keywords: گردش DNA تومور; Cell-free DNA; Circulating tumor DNA; Clonal evolution; Tumor heterogeneity; Treatment resistance; cfDNA; cell-free DNA; ctDNA; circulating tumor DNA;
A Rare STRN-ALK Fusion in Lung Adenocarcinoma Identified Using Next-Generation Sequencing-Based Circulating Tumor DNA Profiling Exhibits Excellent Response to Crizotinib
Keywords: گردش DNA تومور; ctDNA; circulating tumor DNA; MRI; magnetic resonance imaging; NGS; next-generation sequencing; NSCLC; non-small cell lung cancer; STRN; striatin; TKI; tyrosine kinase inhibitor;
Case reportLongitudinal monitoring of ctDNA EGFR mutation burden from urine correlates with patient response to EGFR TKIs: A case series
Keywords: گردش DNA تومور; ctDNA; circulating tumor DNA; LLoD; lower limit of detection; EGFR; Epidermal growth factor receptor; PCR; polymerase chain reaction; TKI; tyrosine kinase inhibitor; GEq; genome equivalent; CT; computerized tomography; q.d.; daily; MRI; magnetic response
Detecting circulating tumor DNA in renal cancer: An open challenge
Keywords: گردش DNA تومور; Circulating tumor DNA; Clear cell RCC; VHL; Colon cancer; KRAS; Next generation sequencing;
Liquid biopsy: An emerging prognostic and predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC). Focus on Circulating Tumor Cells (CTCs)
Keywords: گردش DNA تومور; Liquid biopsy; Head and neck squamous cell carcinoma; Circulating tumor cells; circulating tumor DNA;
Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease
Keywords: گردش DNA تومور; SHOX2; PTGER4; DNA methylation; Lung cancer early detection; Circulating tumor DNA; Liquid biopsy;
Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell Carcinoma
Keywords: گردش DNA تومور; Biomarkers; Cell-free DNA; Circulating tumor DNA; Next generation sequencing; Renal cell carcinoma;
Quels biomarqueurs d'avenir ? Le point de vue des internes en oncologie à l'issue du congrès de l'ESMO 2016
Keywords: گردش DNA تومور; Biomarqueurs; Prédictif; Pronostic; ADN tumoral circulant; Profil génomique; Médecine personnalisée; Biomarkers; Predictive; Prognosis; Circulating tumor DNA; Genomic profile; Personalized medicine;
ReviewClinical value of ctDNA in upper-GI cancers: A systematic review and meta-analysis
Keywords: گردش DNA تومور; Circulating tumor DNA; Esophageal; Gastric; Pancreatic; Meta-analysis;
Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non-Small Cell Lung Cancer
Keywords: گردش DNA تومور; osimertinib; circulating tumor DNA; Roche cobas EGFR Mutation Test; tumor tissue biopsy; MiSeq next-generation sequencing;